BioCompute
PrivateLast Round
Grant
Sep 7, 2024
Total Funding Raised
$24,000
Company Overview
BioCompute operates in AI, Data & Cloud Infrastructure and is based in Toronto. Its latest recorded funding round was a Grant round in September 2024.
BioCompute is a life sciences technology company that provides an AI governance and intelligence platform for pharmaceutical, biotech, and clinical workloads.
Sector
AI, Data & Cloud Infrastructure
Verticals
Drug Discovery, Compliance & Risk, ML Platforms, Data Governance, DevOps & Containers
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioCompute Comparables
Compare BioCompute with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TetraScience | 64% | |
| Databricks | 63% | |
| NVIDIA | 61% |
For institutional investors. Book with your work email.
BioCompute Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 7, 2024 | ||||
| Seed | Jan 17, 2024 | ||||
| Grant | Dec 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioCompute Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 1517 Fund | Seed |
| WTFund | Grant |
| Emergent Ventures | Grant |
| gradCapital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2024
$24K raised from WTFund
- Jan 17, 2024
Seed round raised with participation from 1517 Fund and gradCapital.
For institutional investors. Book with your work email.
BioCompute Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioCompute's valuation, stock price, and market status.
Is BioCompute a public or private company?
BioCompute is a private company.
What is the current stock price of BioCompute?
BioCompute is a private company, so its shares have no public market price. Caplight tracks BioCompute's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioCompute worth (valuation)?
Valuation information for BioCompute is not publicly available.
Can I buy BioCompute stock?
BioCompute shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioCompute's last funding round?
BioCompute's most recent funding round was Grant on September 7, 2024.
Who are the main investors in BioCompute?
Key investors in BioCompute include 1517 Fund, WTFund, Emergent Ventures, gradCapital.
Will BioCompute IPO soon?
No public IPO plans have been announced for BioCompute.
How can I track BioCompute secondary market activity?
Caplight tracks bids, offers, and trades in BioCompute's shares on secondary markets.